|
⚲
|
| Keyboard |
| Peter Hirth | |
|---|---|
| Firm | |
| Address | c/o Trex Holdings Inc 681 Gateway Blvd, 4th Floor South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| TREX Holdings Inc | 021-530561 | Director | 42.3 M of 85.0 M |
||
| Aligos Therapeutics Inc | 021-496669 | Director | 92.2 M of 92.2 M |
||
| Escient Pharmaceuticals Inc | 021-465945 | Director | 60.0 M of 120.0 M |
||
| Escient Pharmaceuticals Inc | 021-374864 | Director | 38.8 M of 77.5 M |
||
| Sutrovax Inc | 021-364301 | Director | 110.0 M of 110.0 M |
||
| Aligos Therapeutics Inc | 021-358226 | Director | 85.0 M of 125.0 M |
||
| Iconic Therapeutics Inc | 021-338229 | Director | 13.0 M of 16.3 M |
||
| Iconic Therapeutics Inc | 021-314821 | Director | 4.1 M of 10.9 M |
||
| Sutrovax Inc | 021-314375 | Director | 43.2 M of 85.7 M |
||
| Sutrovax Inc | 021-282968 | Director | 40.1 M of 60.2 M |
||
| Iconic Therapeutics Inc | 021-254964 | Director | 48.6 M of 48.6 M |
||
| Afferent Pharmaceuticals Inc | 021-243651 | Director | 55.0 M of 55.0 M |
||
| Alios Biopharma Inc | 021-217630 | Director | 41.0 M of 41.0 M |
||
| Kolltan Pharmaceuticals Inc | 021-121462 | Director | 6.0 M of 7.5 M |
||
| Alios Biopharma Inc | 021-96479 | Director | 30.2 M of 34.2 M |
||